Statistics for Biosynex (id:10901 ALBIO)
Valuation metrics
Market cap
29.70M
Enterprise value
81.95M
Trailing P/E (ttm)
5.81
Forward P/E
6.00
PEG ratio
6.00
Price/Sales (ttm)
0.29
Price/Book (mrq)
0.29
Enterprise Value/Revenue
0.79
Enterprise Value/EBITDA
-4.05
Overview
Shares outstanding
10.76M
Float
4.78M
Shares short
% Held by insiders
0.56%
% Held by institutions
0.01%
Average volume (10 days)
3.83K
Average volume (90 days)
Price summary
52-Week low
2.61
52-Week high
8.97
52-Week change
-221.87%
Beta
-2.08
50-Day moving average
3.62
200-Day moving average
4.24
Dividends and splits
Forward annual dividend rate
8.00
Forward annual dividend yield
2.99
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
May 16th, 2022
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
December 31th, 2023
Profitability
Profit margin
-36.98%
Operating margin
-19.27%
Operational effectiveness
Return on assets
-7.13%
Return on equity
-31.52%
Income statement
Revenue (ttm)
9.40
Revenue per share (ttm)
9.40
Quarterly revenue growth (yoy)
Gross profit (ttm)
49.13M
EBITDA
480.00K
Net income to common (ttm)
-38,478,000.00
Diluted EPS (ttm)
-3.46
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
10.74M
Total cash per share (mrq)
1.00
Total debt (mrq)
63.03M
Total Debt/Equity (mrq)
61.07
Current ratio (mrq)
84.30%
Book value per share (mrq)
9.60
Cash flow
Cash flow statement
-10,921,000.00
Levered free cash flow (LFCF)
-7,731,375.00